FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4225679677> ?p ?o ?g. }

• W4225679677 endingPage "381" @default.
• W4225679677 startingPage "371" @default.
• W4225679677 abstract "Objective: To determine whether genomic risk groups identified by somatic mutation testing of colorectal liver metastasis (CRLM) can be used for “molecularly-guided” selection for adjuvant systemic chemotherapy and hepatic artery infusion of FUDR (SYS+HAI-FUDR). Background: Several genomic biomarkers have been associated with clinical phenotype and survival for patients with resectable CRLM. It is unknown whether prognostication afforded by genomic stratification translates into enhanced patient selection for adjuvant hepatic artery infusion therapy. Methods: Consecutive patients with resected CRLM and available mutational characterization via Memorial Sloan Kettering–Integrated Mutation Profiling of Actionable Cancer Targets were reviewed from a prospective institutional database. Patients were stratified into three genomic risk groups based on previously defined alterations in SMAD4 , EGFR and the RAS / RAF pathway. The association between SYS+HAI-FUDR and overall survival, relative to adjuvant chemotherapy alone (SYS), was evaluated in each genomic risk group by Cox proportional hazard regression and propensity score matched analyses. Results: A total of 334 patients (SYS+HAI-FUDR 204; SYS 130) were identified; the rates of RAS/RAF alterations and SMAD4 inactivation were 47.4% and 11.7%, respectively. After a median follow-up of 58 months, adjuvant SYS+HAI-FUDR was independently associated with a reduced risk of death (HR 0.50, 95%CI 0.26–0.98, P = 0.045) in the low-risk genomic group, but not in the moderate-risk (HR 1.07, 95%CI 0.5–2.07, P = 0.749) or high-risk (HR 1.62, 95%CI 0.29–9.12, P = 0.537) cohorts. Following propensity score matching, adjuvant SYS+HAI-FUDR remained associated with significant improvements in long-term survival selectively in the low-risk genomic cohort (5-year actuarial survival: 89% vs. 68%, P = 0.019). Conclusions: Genomic alterations in RAS/RAF , SMAD4, and EGFR may be useful to guide treatment selection in resectable CRLM patients and warrant external validation and integration in future clinical trial design." @default.
• W4225679677 created "2022-05-05" @default.
• W4225679677 creator A5000216315 @default.
• W4225679677 creator A5009465403 @default.
• W4225679677 creator A5010639886 @default.
• W4225679677 creator A5030832720 @default.
• W4225679677 creator A5038333017 @default.
• W4225679677 creator A5042440032 @default.
• W4225679677 creator A5049539733 @default.
• W4225679677 creator A5051277222 @default.
• W4225679677 creator A5055899792 @default.
• W4225679677 creator A5058857144 @default.
• W4225679677 creator A5060380153 @default.
• W4225679677 creator A5060751046 @default.
• W4225679677 creator A5069644669 @default.
• W4225679677 creator A5070901426 @default.
• W4225679677 creator A5079031946 @default.
• W4225679677 creator A5085354954 @default.
• W4225679677 date "2021-11-18" @default.
• W4225679677 modified "2023-09-30" @default.
• W4225679677 title "Genomic Stratification of Resectable Colorectal Liver Metastasis Patients and Implications for Adjuvant Therapy and Survival" @default.
• W4225679677 cites W1553251238 @default.
• W4225679677 cites W1586939666 @default.
• W4225679677 cites W1597604324 @default.
• W4225679677 cites W1964475341 @default.
• W4225679677 cites W1970844261 @default.
• W4225679677 cites W1979423262 @default.
• W4225679677 cites W1992065343 @default.
• W4225679677 cites W2036193982 @default.
• W4225679677 cites W2063985381 @default.
• W4225679677 cites W2084470612 @default.
• W4225679677 cites W2101815035 @default.
• W4225679677 cites W2111635289 @default.
• W4225679677 cites W2122287657 @default.
• W4225679677 cites W2165948908 @default.
• W4225679677 cites W223909586 @default.
• W4225679677 cites W2253928581 @default.
• W4225679677 cites W2316178638 @default.
• W4225679677 cites W2322549182 @default.
• W4225679677 cites W2582236637 @default.
• W4225679677 cites W2607183049 @default.
• W4225679677 cites W2613362156 @default.
• W4225679677 cites W2772293664 @default.
• W4225679677 cites W2792178034 @default.
• W4225679677 cites W2802584856 @default.
• W4225679677 cites W2920006211 @default.
• W4225679677 cites W2952880572 @default.
• W4225679677 cites W2972407726 @default.
• W4225679677 cites W2987342757 @default.
• W4225679677 cites W3080813055 @default.
• W4225679677 cites W3119005666 @default.
• W4225679677 doi "https://doi.org/10.1097/sla.0000000000005315" @default.
• W4225679677 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34793355" @default.
• W4225679677 hasPublicationYear "2021" @default.
• W4225679677 type Work @default.
• W4225679677 citedByCount "2" @default.
• W4225679677 countsByYear W42256796772022 @default.
• W4225679677 countsByYear W42256796772023 @default.
• W4225679677 crossrefType "journal-article" @default.
• W4225679677 hasAuthorship W4225679677A5000216315 @default.
• W4225679677 hasAuthorship W4225679677A5009465403 @default.
• W4225679677 hasAuthorship W4225679677A5010639886 @default.
• W4225679677 hasAuthorship W4225679677A5030832720 @default.
• W4225679677 hasAuthorship W4225679677A5038333017 @default.
• W4225679677 hasAuthorship W4225679677A5042440032 @default.
• W4225679677 hasAuthorship W4225679677A5049539733 @default.
• W4225679677 hasAuthorship W4225679677A5051277222 @default.
• W4225679677 hasAuthorship W4225679677A5055899792 @default.
• W4225679677 hasAuthorship W4225679677A5058857144 @default.
• W4225679677 hasAuthorship W4225679677A5060380153 @default.
• W4225679677 hasAuthorship W4225679677A5060751046 @default.
• W4225679677 hasAuthorship W4225679677A5069644669 @default.
• W4225679677 hasAuthorship W4225679677A5070901426 @default.
• W4225679677 hasAuthorship W4225679677A5079031946 @default.
• W4225679677 hasAuthorship W4225679677A5085354954 @default.
• W4225679677 hasBestOaLocation W42256796772 @default.
• W4225679677 hasConcept C121608353 @default.
• W4225679677 hasConcept C126322002 @default.
• W4225679677 hasConcept C143998085 @default.
• W4225679677 hasConcept C207103383 @default.
• W4225679677 hasConcept C2777863537 @default.
• W4225679677 hasConcept C2779013556 @default.
• W4225679677 hasConcept C44249647 @default.
• W4225679677 hasConcept C50382708 @default.
• W4225679677 hasConcept C526805850 @default.
• W4225679677 hasConcept C71924100 @default.
• W4225679677 hasConceptScore W4225679677C121608353 @default.
• W4225679677 hasConceptScore W4225679677C126322002 @default.
• W4225679677 hasConceptScore W4225679677C143998085 @default.
• W4225679677 hasConceptScore W4225679677C207103383 @default.
• W4225679677 hasConceptScore W4225679677C2777863537 @default.
• W4225679677 hasConceptScore W4225679677C2779013556 @default.
• W4225679677 hasConceptScore W4225679677C44249647 @default.
• W4225679677 hasConceptScore W4225679677C50382708 @default.
• W4225679677 hasConceptScore W4225679677C526805850 @default.
• W4225679677 hasConceptScore W4225679677C71924100 @default.
• W4225679677 hasIssue "2" @default.
• W4225679677 hasLocation W42256796771 @default.

• next